Correlation between protein-polydimethylsiloxane visible particle formation and computationally derived antibody

Kazunori Hirayama1, Kengo Arai1, Masakazu Fukuda1

  • 1Formulation Development Department, Chugai Pharmaceutical Co., Ltd., 5-5-1 Ukima, Kita-ku, Tokyo 115-8543, Japan.

Summary

Researchers developed a computational method to predict protein aggregation risk in drug formulations. This approach identifies key protein surface features, aiding in the design of safer biologic drugs and preventing visible particle formation.

Related Concept Videos